Ye Bi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ye Bi has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Lesheng Teng
School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun 130012, P. R. China
6 shared publications - Robert J. Lee
Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
3 shared publications Jie Feng
School of Life Sciences
2 shared publications- Jing Xie
School of Life Sciences, Jilin University, Changchun 130012, China
2 shared publications - Lianlian Li
School of Life Sciences, Jilin University, Changchun 130117, China
2 shared publications Yuhong Man
Second Hosp Jilin Univ, Dept Neurol, Changchun 130041, Peoples R China
2 shared publications
Latest Publications
- 22 June 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (26) , 8531-8541
Cell-Penetrating Peptide Conjugated Polyzwitterion-Drug Enhances Tumor Retention
The dense microenvironment of triple-negative breast cancer (TNBC) poses a formidable barrier to nanomedicine penetration, rendering selective tumor retention critical for effective drug delivery. Cell-penetrating peptides (CPPs)-PEG polymers improve SN38 cellular uptake but lack tumor selectivity. We employed a quantitative structure–activity relationship (QSAR)-driven strategy to screen a combinatorial CPPs library for tumor microenvironment responsiveness. We elucidated that proline residues induce peptide bending and steric effects, resulting in PEG shield to limit cargo cellular entry. Eliminating these residues abrogated structural kinks, yielding a linearized peptide topology that effectively pierced the PEG shell to engage anionic membrane receptors, thereby enhancing tumor penetration and intracellular accumulation. Consequently, the optimized TAT12-PEG-SN38 micelles prolonged blood circulation and suppressed TNBC growth and metastasis. Furthermore, combination treatment with JQ-1 attenuated immune evasion. Overall, peptide structure engineering overcomes the PEG barrier, providing a practical strategy for developing novel peptide–drug conjugates.
- 22 June 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (26) , 8531-8541
Cell-Penetrating Peptide Conjugated Polyzwitterion-Drug Enhances Tumor Retention
The dense microenvironment of triple-negative breast cancer (TNBC) poses a formidable barrier to nanomedicine penetration, rendering selective tumor retention critical for effective drug delivery. Cell-penetrating peptides (CPPs)-PEG polymers improve SN38 cellular uptake but lack tumor selectivity. We employed a quantitative structure–activity relationship (QSAR)-driven strategy to screen a combinatorial CPPs library for tumor microenvironment responsiveness. We elucidated that proline residues induce peptide bending and steric effects, resulting in PEG shield to limit cargo cellular entry. Eliminating these residues abrogated structural kinks, yielding a linearized peptide topology that effectively pierced the PEG shell to engage anionic membrane receptors, thereby enhancing tumor penetration and intracellular accumulation. Consequently, the optimized TAT12-PEG-SN38 micelles prolonged blood circulation and suppressed TNBC growth and metastasis. Furthermore, combination treatment with JQ-1 attenuated immune evasion. Overall, peptide structure engineering overcomes the PEG barrier, providing a practical strategy for developing novel peptide–drug conjugates.
- 30 September 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 685, 126234
A transdermal drug delivery system based on estradiol liposomes enhances the alleviation of psoriatic skin inflammation
- 30 September 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 685, 126234
A transdermal drug delivery system based on estradiol liposomes enhances the alleviation of psoriatic skin inflammation
- 23 October 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 205, 114565
A size-switchable microsphere loaded with salmon calcitonin as two-weekly dosing for osteoporosis therapy
- 23 October 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 205, 114565
A size-switchable microsphere loaded with salmon calcitonin as two-weekly dosing for osteoporosis therapy
- Open Access
- 3 May 2024
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 198, 106783
Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis
- 3 May 2024
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 198, 106783
Open AccessHyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis
- Open Access
- 1 February 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 1525-1551
Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
Nanomedicines afford unique advantages in therapeutic intervention against tumors. However, conventional nanomedicines have failed to achieve the desired effect against cancers because of the presence of complicated physiological fluids and the tumor microenvironment. Stimuli-responsive drug-delivery systems have emerged as potential tools for advanced treatment of cancers. Versatile nano-carriers co-triggered by multiple stimuli in different levels of organisms (eg, extracorporeal, tumor tissue, cell, subcellular organelles) have aroused widespread interest because they can overcome sequential physiological and pathological barriers to deliver diverse therapeutic “payloads” to the desired targets. Furthermore, multiple stimuli-responsive drug-delivery systems (MSR-DDSs) offer a good platform for co-delivery of agents and reversing multidrug resistance. This review affords a comprehensive overview on the “landscape” of MSR-DDSs against tumors, highlights the design strategies of MSR-DDSs in recent years, discusses the putative advantage of oncotherapy or the obstacles that so far have hindered the clinical translation of MSR-DDSs.
- 1 February 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 1525-1551
Open AccessAdvances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
Nanomedicines afford unique advantages in therapeutic intervention against tumors. However, conventional nanomedicines have failed to achieve the desired effect against cancers because of the presence of complicated physiological fluids and the tumor microenvironment. Stimuli-responsive drug-delivery systems have emerged as potential tools for advanced treatment of cancers. Versatile nano-carriers co-triggered by multiple stimuli in different levels of organisms (eg, extracorporeal, tumor tissue, cell, subcellular organelles) have aroused widespread interest because they can overcome sequential physiological and pathological barriers to deliver diverse therapeutic “payloads” to the desired targets. Furthermore, multiple stimuli-responsive drug-delivery systems (MSR-DDSs) offer a good platform for co-delivery of agents and reversing multidrug resistance. This review affords a comprehensive overview on the “landscape” of MSR-DDSs against tumors, highlights the design strategies of MSR-DDSs in recent years, discusses the putative advantage of oncotherapy or the obstacles that so far have hindered the clinical translation of MSR-DDSs.
- Open Access
A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine
Proliposomes were used to improve the solubility and oral bioavailability of nifedipine. Nifedipine proliposomes were prepared by methanol injection-spray drying method. The response surface method was used to optimize formulation to enhance the encapsulation efficiency (EE%) of nifedipine. The particle size of nifedipine proliposomes after rehydration was 114 nm. Surface morphology of nifedipine proliposomes was observed by a scanning electron microscope (SEM) and interaction of formulation ingredients was assessed by differential scanning calorimetry (DSC). The solubility of nifedipine is improved 24.8 times after forming proliposomes. In vitro release experiment, nifedipine proliposomes had a control release effect, especially in simulated gastric fluid. In vivo, nifedipine proliposomes significantly improved the bioavailability of nifedipine. The area under the concentration-time curve (AUC0–∞) of nifedipine proliposomes was about 10 times than nifedipine after oral administration. The elimination half-life (T1/2β) of nifedipine was increased from 1.6 h to 6.6 h. In conclusion, proliposomes was a promising system to deliver nifedipine through oral route and warranted further investigation.
Open AccessA Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine
Proliposomes were used to improve the solubility and oral bioavailability of nifedipine. Nifedipine proliposomes were prepared by methanol injection-spray drying method. The response surface method was used to optimize formulation to enhance the encapsulation efficiency (EE%) of nifedipine. The particle size of nifedipine proliposomes after rehydration was 114 nm. Surface morphology of nifedipine proliposomes was observed by a scanning electron microscope (SEM) and interaction of formulation ingredients was assessed by differential scanning calorimetry (DSC). The solubility of nifedipine is improved 24.8 times after forming proliposomes. In vitro release experiment, nifedipine proliposomes had a control release effect, especially in simulated gastric fluid. In vivo, nifedipine proliposomes significantly improved the bioavailability of nifedipine. The area under the concentration-time curve (AUC0–∞) of nifedipine proliposomes was about 10 times than nifedipine after oral administration. The elimination half-life (T1/2β) of nifedipine was increased from 1.6 h to 6.6 h. In conclusion, proliposomes was a promising system to deliver nifedipine through oral route and warranted further investigation.
- Open Access
- 3 July 2019
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (7) , 311
Liposomal Vitamin D3 as an Anti-aging Agent for the Skin
Vitamin D3 is an effective skin protective substance to prevent photoaging. Liposomes were used as a carrier to deliver vitamin D3 to improve the stability and to enhance the treatment effect of vitamin D3. The stability of vitamin D3 liposomes, average cumulative penetration, and retention of vitamin D3 in the skin were then evaluated and compared with free vitamin D3. Finally, the treatment effect of vitamin D3 liposomes in a rat photoaging model was appraised and Haematoxylin-Eosin (H&E) staining was used to assess the histology changes of the skin after vitamin D3 liposome treatment. The results indicated that liposomes could significantly improve the stability of vitamin D3. The average skin retention of vitamin D3 liposomes was 1.65 times that of the vitamin D3 solution. Vitamin D3 liposomes could repair the surface morphology of skin in the photoaging model and promote the production of new collagen fibers. Vitamin D3 liposomes as a potential skin care agent could significantly improve skin appearance and repair damage in the histology of photoaging.
- 3 July 2019
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (7) , 311
Open AccessLiposomal Vitamin D3 as an Anti-aging Agent for the Skin
Vitamin D3 is an effective skin protective substance to prevent photoaging. Liposomes were used as a carrier to deliver vitamin D3 to improve the stability and to enhance the treatment effect of vitamin D3. The stability of vitamin D3 liposomes, average cumulative penetration, and retention of vitamin D3 in the skin were then evaluated and compared with free vitamin D3. Finally, the treatment effect of vitamin D3 liposomes in a rat photoaging model was appraised and Haematoxylin-Eosin (H&E) staining was used to assess the histology changes of the skin after vitamin D3 liposome treatment. The results indicated that liposomes could significantly improve the stability of vitamin D3. The average skin retention of vitamin D3 liposomes was 1.65 times that of the vitamin D3 solution. Vitamin D3 liposomes could repair the surface morphology of skin in the photoaging model and promote the production of new collagen fibers. Vitamin D3 liposomes as a potential skin care agent could significantly improve skin appearance and repair damage in the histology of photoaging.
- 27 December 2018
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 39 (1) , 237-243
Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood–Brain Barrier
Background/Aim: Glioma is a deadly form of brain cancer. Doxorubicin is cytotoxic against glioma cells. However, the blood-brain barrier (BBB) limits its ability to be delivered to the brain. Materials and Methods: Liposomes (R8PLP) formed from, 1,2-dioleoyl-3-trimethylammonium-propane chloride (DOTAP), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy-(polyethylene glycol)-2000] (PEG-DSPE), cholesterol and egg phosphatidylcholine (ePC) were modified by cell-penetrating peptide R8 conjugated with oleic acid as a novel method for delivering doxorubicin. The antitumor effect of R8PLP was evaluated by uptake, cytotoxicity and brain accumulation. Results: The size of R8PLP was 95 nm. Doxorubicin was loaded into R8PLP by active loading with more than 95% encapsulation efficiency. Cellular uptake of R8PLP by U87-MG cells was 8.6-fold higher than that of unmodified liposomes. R8PLP reduced cell viability by 16.18% and 18.11% compared to cholesterol-ePC-liposomes and free doxorubicin, respectively, at 3.6 μM after 24 h treatment. The biodistribution of doxorubicin in the brain was significantly improved by R8PLP. The area under the concentration-time curve (AUC0.5-12 h) of R8PLP was 2.4-times higher than that of cholesterol-ePC-PEG-DSPE-liposomes. Conclusion: These results suggest that R8-conjugated oleic acid-modified liposomes are effective delivery vehicles for glioma.
- 27 December 2018
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 39 (1) , 237-243
Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood–Brain Barrier
Background/Aim: Glioma is a deadly form of brain cancer. Doxorubicin is cytotoxic against glioma cells. However, the blood-brain barrier (BBB) limits its ability to be delivered to the brain. Materials and Methods: Liposomes (R8PLP) formed from, 1,2-dioleoyl-3-trimethylammonium-propane chloride (DOTAP), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy-(polyethylene glycol)-2000] (PEG-DSPE), cholesterol and egg phosphatidylcholine (ePC) were modified by cell-penetrating peptide R8 conjugated with oleic acid as a novel method for delivering doxorubicin. The antitumor effect of R8PLP was evaluated by uptake, cytotoxicity and brain accumulation. Results: The size of R8PLP was 95 nm. Doxorubicin was loaded into R8PLP by active loading with more than 95% encapsulation efficiency. Cellular uptake of R8PLP by U87-MG cells was 8.6-fold higher than that of unmodified liposomes. R8PLP reduced cell viability by 16.18% and 18.11% compared to cholesterol-ePC-liposomes and free doxorubicin, respectively, at 3.6 μM after 24 h treatment. The biodistribution of doxorubicin in the brain was significantly improved by R8PLP. The area under the concentration-time curve (AUC0.5-12 h) of R8PLP was 2.4-times higher than that of cholesterol-ePC-PEG-DSPE-liposomes. Conclusion: These results suggest that R8-conjugated oleic acid-modified liposomes are effective delivery vehicles for glioma.